Recursion Pharmaceuticals
RXRX
#4202
Rank
$1.98 B
Marketcap
$4.94
Share price
-6.52%
Change (1 day)
-43.61%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Cash on Hand

Cash on Hand as of December 2024 : $0.59 Billion USD

According to Recursion Pharmaceuticals's latest financial reports the company has $0.59 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.59 B51.79%
2023-12-31$0.39 B-28.79%
2022-12-31$0.54 B6.46%
2021-12-31$0.51 B97.07%
2020-12-31$0.26 B275.09%
2019-12-31$69.88 M